Jacob L. Glass

Hematology | Oncology

505 E 70th St
Weill Cornell Internal Medicine Associates, Box 148
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution.

Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution.

Journal: The Journal of clinical investigation

Published: July 21, 2026

TET2 and TP53 Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic Transformation.

TET2 and TP53 Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic Transformation.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 29, 2025

Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.

Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.

Journal: Blood

Published: July 22, 2024

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia.

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia.

Journal: Blood neoplasia

Published: May 30, 2024

The power and perils of large language models in haematology.

The power and perils of large language models in haematology.

Journal: British journal of haematology

Published: May 10, 2024

Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

Journal: Histopathology

Published: January 22, 2024

Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticity.

Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticity.

Journal: medRxiv : the preprint server for health sciences

Published: November 14, 2023

Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.

Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.

Journal: Leukemia research

Published: March 31, 2023

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.

Journal: Blood advances

Published: January 12, 2023

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.

Journal: Blood advances

Published: October 24, 2022

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Journal: Cancer discovery

Published: August 26, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026